Atrial Fibrillation

Detecting Biomarkers of Early Atrial Transformation in AF

Study Scope and Process

This large scale 3,000 patient atrial fibrillation study spans up to 10 years, and is designed to detect biomarkers of early atrial transformation in atrial fibrillation.

​During the study, VivaLNK multi-function cardiac patches are used in remote patient monitoring settings to capture the ECG rhythm of subjects one week per month for extended periods.

ambulatory remote patient monitoring

Challenges Addressed

  • Patient self application
  • Customized enrollment app
  • ECG algorithm integration

Parameters Captured

  • Raw ECG rhythm
  • Heart rate
  • RR-interval
Contact VivaLNK

Want more information?

See How VivaLNK Can Help Your Company